TVGNW
Tevogen Bio Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.05
+1.36%Price chart
Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.7x
Market Cap
$10.21M
MomentumView details →
1D Return
+1.36%
YTD Return
+17.77%
RSI (14)
48.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.7x
Market Cap
$10.21M
RSI (14)
48.3
MomentumView details →
1D Return
+1.36%
YTD Return
+17.77%
Similar companies
Latest newsMore news →
Tevogen Inc. elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors, effective August 24, 2026.10d agoShort interest in Tevogen Bio Holdings Inc. increased by 4,063.1% to 81,430 shares as of July 31, 2026, from 1,956 shares on July 15, 2026.23d agoTevogen Bio Holdings Inc. announced it will operate under the name Tevogen Inc. following board approval.38d ago